Magnesium deficiency results in an increased formation of osteoclasts

Journal of Nutritional Biochemistry

Volumn 24, Issue 8, 2013, Pages 1488-1498

  Belluci, Marina M ^a,b   Schoenmaker, Ton ^b   Rossa Junior, Carlos ^a   Orrico, Silvana R ^a   de Vries, Teun J ^b   Everts, Vincent ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Bone marrow; Bone metabolism; Magnesium deficiency; Osteoclast; Osteoclast activity; Osteoclastogenesis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCIUM ION; CALPAIN 1; CALPAIN 2; DENDRITIC CELL SPECIFIC TRANSMEMBRANE PROTEIN; INTERLEUKIN 1BETA; MAGNESIUM; MEMBRANE PROTEIN; MESSENGER RNA; MRS2 PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PORPHOBILINOGEN DEAMINASE; PROTEIN; PROTEIN C FOS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; INCUBATION TIME; MAGNESIUM DEFICIENCY; MALE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHENOTYPE;

BONE MARROW; BONE METABOLISM; MAGNESIUM DEFICIENCY; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS;

ACID PHOSPHATASE; ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE MARROW CELLS; CALCIUM; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ISOENZYMES; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MICE; MICE, INBRED C57BL; OSTEOCLASTS; RNA, MESSENGER;

MUS;

EID: 84892437002     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.12.008     Document Type: Article

References (48)

1. Rude R.K., Gruber H.E., Norton H.J., et al. Dietary magnesium reduction to 25% of nutrient requirement disrupts bone and mineral metabolism in the rat. Bone 2005, 37:211-219.
2. Rude R.K., Gruber H.E., Norton H.J., et al. Bone loss induced by dietary magnesium reduction to 10% of the nutrient requirement in rats is associated with increased release of substance P and tumor necrosis factor-alpha. J Nutr 2004, 134:79-85.
3. Stendig-Lindberg G., Koeller W., Bauer A., Rob P.M. Experimentally induced prolonged magnesium deficiency causes osteoporosis in the rat. Eur J Intern Med 2004, 15:97-107.
4. Ilich J.Z., Brownbill R.A., Tamborini L. Bone and nutrition in elderly women: protein, energy, and calcium as main determinants of bone mineral density. Eur J Clin Nutr 2003, 57:554-565.
5. Ilich J.Z., Kerstetter J.E. Nutrition in bone health revisited: a story beyond calcium. J Am Coll Nutr 2000, 19:715-737.
6. Wacker W.E., Parisi A.F. Magnesium metabolism. N Engl J Med 1968, 278:658-663.
7. Maguire M.E., Cowan J.A. Magnesium chemistry and biochemistry. Biometals 2002, 15:203-210.
8. Rude R.K., Kirchen M.E., Gruber H.E., et al. Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption. Magnes Res 1999, 12:257-267.
9. Wolf F.I., Trapani V. Cell (patho)physiology of magnesium. Clin Sci (Lond) 2008, 114:27-35.
10. Schimatschek H.F., Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res 2001, 14:283-290.
11. Touvier M., Lioret S., Vanrullen I., et al. Vitamin and mineral inadequacy in the French population: estimation and application for the optimization of food fortification. Int J Vitam Nutr Res 2006, 76:343-351.
12. Galan P., Preziosi P., Durlach V., et al. Dietary magnesium intake in a French adult population. Magnes Res 1997, 10:321-328.
13. Welch A.A., Fransen H., Jenab M., et al. Variation in intakes of calcium, phosphorus, magnesium, iron and potassium in 10 countries in the European Prospective Investigation into Cancer and Nutrition study. Eur J Clin Nutr 2009, 63(Suppl 4):S101-S121.
14. Rude R.K. Magnesium deficiency: a cause of heterogeneous disease in humans. J Bone Miner Res 1998, 13:749-758.
15. Vormann J. Magnesium: nutrition and metabolism. Mol Aspects Med 2003, 24:27-37.
16. Rude R.K., Gruber H.E., Wei L.Y., et al. Magnesium deficiency: effect on bone and mineral metabolism in the mouse. Calcif Tissue Int 2003, 72:32-41.
17. Rude R.K., Gruber H.E., Norton H.J., et al. Reduction of dietary magnesium by only 50% in the rat disrupts bone and mineral metabolism. Osteoporos Int 2006, 17:1022-1032.
18. Belluci M.M., Giro G., del Barrio R.A., et al. Effects of magnesium intake deficiency on bone metabolism and bone tissue around osseointegrated implants. Clin Oral Implants Res 2011, 22:716-721.
19. Del Barrio R.A., Giro G., Belluci M.M., et al. Effect of severe dietary magnesium deficiency on systemic bone density and removal torque of osseointegrated implants. Int J Oral Maxillofac Implants 2010, 25:1125-1130.
20. Mazur A., Maier J.A., Rock E., et al. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 2007, 458:48-56.
21. Schett G. Effects of inflammatory and anti-inflammatory cytokines on the bone. Eur J Clin Invest 2011.
22. Henriksen K., Bollerslev J., Everts V., Karsdal M.A. Osteoclast activity and subtypes as a function of physiology and pathology - implications for future treatments of osteoporosis. Endocr Rev 2011, 32:31-63.
23. Li C.Y., Price C., Delisser K., et al. Long-term disuse osteoporosis seems less sensitive to bisphosphonate treatment than other osteoporosis. J Bone Miner Res 2005, 20:117-124.
24. van Beek E.M., de Vries T.J., Mulder L., et al. Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha. FASEB J 2009, 23:4081-4090.
25. Everts V., de Vries T.J., Helfrich M.H. Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. Biochim Biophys Acta 2009, 1792:757-765.
26. Everts V., Korper W., Hoeben K.A., et al. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J Bone Miner Res 2006, 21:1399-1408.
27. Everts V., Korper W., Jansen D.C., et al. Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J 1999, 13:1219-1230.
28. Sodek K.L., Tupy J.H., Sodek J., Grynpas M.D. Relationships between bone protein and mineral in developing porcine long bone and calvaria. Bone 2000, 26:189-198.
29. de Souza Faloni A.P., Schoenmaker T., Azari A., et al. Jaw and long bone marrows have a different osteoclastogenic potential. Calcif Tissue Int 2011, 88:63-74.
30. de Vries T.J., Schoenmaker T., Beertsen W., et al. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation. J Cell Biochem 2005, 94:954-966.
31. de Vries T.J., Schoenmaker T., Hooibrink B., et al. Myeloid blasts are the mouse bone marrow cells prone to differentiate into osteoclasts. J Leukoc Biol 2009, 85:919-927.
32. Azari A., Schoenmaker T., de Souza Faloni A.P., et al. Jaw and long bone marrow derived osteoclasts differ in shape and their response to bone and dentin. Biochem Biophys Res Commun 2011, 409:205-210.
33. Abed E., Moreau R. Importance of melastatin-like transient receptor potential 7 and cations (magnesium, calcium) in human osteoblast-like cell proliferation. Cell Prolif 2007, 40:849-865.
34. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
35. Matsuo K., Owens J.M., Tonko M., et al. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet 2000, 24:184-187.
36. Lee B., Kim T.H., Jun J.B., et al. Direct inhibition of human RANK+ osteoclast precursors identifies a homeostatic function of IL-1beta. J Immunol 2010, 185:5926-5934.
37. Tani-Ishii N., Tsunoda A., Teranaka T., Umemoto T. Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha. J Dent Res 1999, 78:1617-1623.
38. Romani A.M. Cellular magnesium homeostasis. Arch Biochem Biophys 2011, 512:1-23.
39. Gruber H.E., Rude R.K. Alterations in osteoclast morphology following osteoprotegerin administration in the magnesium-deficient mouse. Biotech Histochem 2003, 78:231-236.
40. Andersson G., Johansson E.K. Adhesion of human myelomonocytic (HL-60) cells induced by 1,25-dihydroxyvitamin D3 and phorbol myristate acetate is dependent on osteopontin synthesis and the alpha v beta 3 integrin. Connect Tissue Res 1996, 35:163-171.
41. Kido S., Inoue D., Hiura K., et al. Expression of RANK is dependent upon differentiation into the macrophage/osteoclast lineage: induction by 1alpha,25-dihydroxyvitamin D3 and TPA in a human myelomonocytic cell line, HL60. Bone 2003, 32:621-629.
42. Somerman M.J., Berry J.E., Khalkhali-Ellis Z., et al. Enhanced expression of alpha v integrin subunit and osteopontin during differentiation of HL-60 cells along the monocytic pathway. Exp Cell Res 1995, 216:335-341.
43. Yoneda T., Alsina M.M., Garcia J.L., Mundy G.R. Differentiation of HL-60 cells into cells with the osteoclast phenotype. Endocrinology 1991, 129:683-689.
44. Flores C., de Vries T.J., Moscatelli I., et al. Nonablative neonatal bone marrow transplantation rapidly reverses severe murine osteopetrosis despite low-level engraftment and lack of selective expansion of the osteoclastic lineage. J Bone Miner Res 2010, 25:2069-2077.
45. Bussiere F.I., Gueux E., Rock E., et al. Increased phagocytosis and production of reactive oxygen species by neutrophils during magnesium deficiency in rats and inhibition by high magnesium concentration. Br J Nutr 2002, 87:107-113.
46. Malpuech-Brugere C., Nowacki W., Daveau M., et al. Inflammatory response following acute magnesium deficiency in the rat. Biochim Biophys Acta 2000, 1501:91-98.
47. Bussiere F.I., Tridon A., Zimowska W., et al. Increase in complement component C3 is an early response to experimental magnesium deficiency in rats. Life Sci 2003, 73:499-507.
48. Malpuech-Brugere C., Nowacki W., Rock E., et al. Enhanced tumor necrosis factor-alpha production following endotoxin challenge in rats is an early event during magnesium deficiency. Biochim Biophys Acta 1999, 1453:35-40.